Psilocybin Shows Early Promise for Anorexia, But Proof Is Thin
Health Science·November 2, 2026
A small clinical trial suggests that psilocybin, the psychedelic compound found in magic mushrooms, may help some people with anorexia when it is combined with intensive therapy. The findings were discussed on the Scientific American podcast Science Quickly, where host Rachel Feltman spoke with health journalist Alexandra Pattillo about what early research has found so far. The short version: the results are encouraging, but they are far from conclusive.
Anorexia nervosa carries one of the highest death rates of any psychiatric illness, and the treatment options are limited. Standard care usually centers on nutritional rehabilitation and psychotherapy, and relapse is common. That gap is a big reason researchers have been looking at unconventional approaches.
The reasoning behind the idea is that eating disorders often involve rigid patterns of thinking, such as fixed rules about food, intense perfectionism and anxiety that is hard to shift through conversation alone. Scientists believe psychedelics may temporarily loosen those patterns, making the brain more flexible and giving patients a chance to engage with therapy in new ways. Psilocybin has already drawn attention for similar reasons in studies of depression and other conditions, where it is typically given in a supervised setting alongside therapy rather than on its own.
Experts are careful not to oversell the result. A small sample can make a promising signal look stronger than it is, and it is hard to know from a handful of participants who might benefit most or how long any improvement would last. Psychedelic sessions can also bring intense or distressing experiences, which is one reason any future use would need close clinical oversight.
Larger, controlled trials would be needed to test whether the effect holds up, to identify which patients might respond, and to measure safety over time. Interest in psychedelic medicine has grown quickly in recent years, and renewed government attention could speed up research. But for now, the science is still at the starting line, and anyone with anorexia should be guided by established medical care rather than self-treatment.